Madrigal Pharmaceuticals, Inc. Share Price
Stocks
MDGL
US5588681057
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 551.25 USD | +1.24% |
|
-0.40% | -5.34% |
| 27/07 | Wells Fargo Initiates Madrigal Pharmaceuticals at Overweight With $685 Price Target | MT |
| 22/07 | BofA Securities Adjusts Price Target on Madrigal Pharmaceuticals to $553 From $542 | MT |
| Market Cap | 1.26TCr 1.1TCr 1.03TCr 944.76Cr 1.77TCr 1,20400Cr 1.8TCr 12TCr 4.77TCr 59TCr 4.71TCr 4.61TCr 2,05500Cr | P/E 2026 * |
-76.3x | P/E 2027 * | 63.3x |
|---|---|---|---|---|---|
| Enterprise Value | 1.2TCr 1.06TCr 985.72Cr 905.99Cr 1.7TCr 1,15500Cr 1.72TCr 12TCr 4.57TCr 57TCr 4.52TCr 4.42TCr 1,97100Cr | EV / Sales 2026 * |
8.02x | EV / Sales 2027 * | 5.26x |
| Free-Float |
94.11% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Madrigal Pharmaceuticals, Inc.
| 1 day | +1.24% | ||
| 1 week | -0.40% | ||
| Current month | +2.66% | ||
| 1 month | +7.53% | ||
| 3 months | +7.58% | ||
| 6 months | +10.43% | ||
| Current year | -5.34% |
| 1 week | 526.6 |  | 566.18 |
| 1 month | 506 | | 569.44 |
| Current year | 416.21 | | 598.79 |
| 1 year | 286.44 | | 615 |
| 3 years | 119.76 | | 615 |
| 5 years | 52.33 | | 615 |
| 10 years | 6.6 | | 615 |
| Manager | Title | Age | Since |
|---|---|---|---|
William Sibold
CEO | Chief Executive Officer | 59 | 08/09/2023 |
Mardi Dier
DFI | Director of Finance/CFO | 62 | 11/03/2024 |
David Soergel
CTO | Chief Tech/Sci/R&D Officer | 58 | 21/04/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Rebecca Taub
BRD | Director/Board Member | 74 | 01/07/2016 |
Richard Levy
BRD | Director/Board Member | 68 | 11/08/2016 |
James Daly
BRD | Director/Board Member | 64 | 27/06/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 20/07/26 | Sell | Chief Executive Officer | -2,500 | 0.0108% | ||
| 17/06/26 | Free | Founder | 1,220 | 0.0053% | ||
| 17/06/26 | Free | Director | 1,085 | 0.0047% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.24% | -0.40% | +84.74% | +173.79% | 1.26TCr | |
| -1.82% | +5.03% | +56.71% | +66.69% | 5.73TCr | |
| -0.27% | +5.74% | +40.26% | +80.17% | 5.5TCr | |
| -2.05% | -3.31% | +0.75% | +414.39% | 2.32TCr | |
| +1.97% | -0.43% | -21.00% | -13.67% | 2.26TCr | |
| -1.13% | +4.54% | +22.73% | -8.06% | 2.05TCr | |
| +1.57% | +2.09% | +28.01% | -27.56% | 1.76TCr | |
| -0.10% | +5.57% | +38.63% | +565.16% | 1.57TCr | |
| +5.29% | 0.00% | +185.09% | +332.66% | 1.45TCr | |
| +0.79% | -0.20% | +22.39% | +181.58% | 1.39TCr | |
| Average | +0.43% | +1.29% | +45.83% | +176.52% | 2.53TCr | |
| Weighted average by Cap. | -0.17% | +1.76% | +42.03% | +139.51% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 150.03Cr 131.98Cr 122.84Cr 112.91Cr 211.87Cr 14TCr 214.72Cr 1.46TCr 570.13Cr 7.1TCr 563.2Cr 551.06Cr 25TCr | 218.29Cr 192.02Cr 178.73Cr 164.28Cr 308.26Cr 21TCr 312.41Cr 2.12TCr 829.5Cr 10TCr 819.42Cr 801.76Cr 36TCr |
| Net income | -20Cr -18Cr -17Cr -15Cr -29Cr -1.96TCr -29Cr -198.28Cr -78Cr -965.75Cr -77Cr -75Cr -3.34TCr | 27Cr 23Cr 22Cr 20Cr 38Cr 2.56TCr 38Cr 259.15Cr 101.33Cr 1.26TCr 100.1Cr 98Cr 4.37TCr |
| Net Debt | -52Cr -45Cr -42Cr -39Cr -73Cr -4.94TCr -74Cr -500.63Cr -195.76Cr -2.44TCr -193.38Cr -189.21Cr -8.43TCr | -107.6Cr -95Cr -88Cr -81Cr -151.95Cr -10TCr -153.99Cr -1.05TCr -408.88Cr -5.09TCr -403.91Cr -395.21Cr -18TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 27/26/27 | $551.25 | +1.24% | 2,68,595 |
| 24/26/24 | $544.51 | +0.21% | 1,47,390 |
| 23/26/23 | $543.35 | +1.06% | 1,60,514 |
| 22/26/22 | $537.65 | -1.67% | 3,10,899 |
| 21/26/21 | $546.79 | +2.07% | 2,22,279 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- MDGL Stock
Select your edition
All financial news and data tailored to specific country editions
